Alan M. Garber
Director, Exelixis.
Companies
- Vertex PharmaceuticalsBoard member Jun 9, 2017 to now1
- ExelixisBoard member May 3, 2006 to Mar 25, 20242
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Vertex Pharmaceuticals VRTX7,344 shares3$3.7M at $499.29May 1, 2026
Exelixis EXEL35,703 shares4$2.2M at $62.23Mar 21, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- May 1, 2026Granted 472 shares of Vertex Pharmaceuticals3
- May 1, 2025Granted 398 shares of Vertex Pharmaceuticals5
- Mar 21, 2024Sold 19,205 shares at $24.01 of Exelixis4
- Mar 21, 2024Exercised options 23,491 shares at $19.57 of Exelixis4
- May 1, 2023Granted 584 shares of Vertex Pharmaceuticals6
- Feb 21, 2023Sold 40,000 shares at $17.49 of Exelixis7
- Feb 21, 2023Exercised options 40,000 shares at $6.30 of Exelixis7
- Mar 1, 2022Sold 21,301 shares at $21.00 of Exelixis8
- Mar 1, 2022Exercised options 40,000 shares at $3.13 of Exelixis8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARVertex Pharmaceuticals, Board member
- 2SEC EDGARExelixis, Board member
- 3
- 4
- 5SEC EDGARForm 4 filed May 5, 2025
- 6SEC EDGARForm 4 filed May 3, 2023
- 7SEC EDGARForm 4 filed Feb 23, 2023
- 8SEC EDGARForm 4 filed Mar 3, 2022